Maresin-1改善青少年期抑郁小鼠的抑郁样行为和神经炎症

陈羽佳, 石磊, 徐何雁, 王余娜, 杜宁, 彭志平, 邱大川, 夏铸, 况利

PDF(1943 KB)
PDF(1943 KB)
重庆医科大学学报 ›› 2024, Vol. 49 ›› Issue (04) : 465-470. DOI: 10.13406/j.cnki.cyxb.003469
基础研究

Maresin-1改善青少年期抑郁小鼠的抑郁样行为和神经炎症

作者信息 +

Improvement of depression-like behaviors and neuroinflammation in adolescent depressed mice using Maresin-1

Author information +
History +

摘要

目的 阐明Maresin-1(MaR1)对慢性社交挫败(chronic social defeated stress,CSDS)诱导青少年期(5~8周)小鼠抑郁样行为的影响,验证其在CSDS诱导的神经炎症中的作用,为理解抑郁症的分子机制和探索生物标志物提供参考。 方法 利用多种方法来检测CSDS诱导10 d后C57BL/6J小鼠的抑郁样行为和神经炎症。并每2 d注射1次MaR1(5 µg/kg)治疗小鼠,以观察其对CSDS诱导的抑郁样行为和神经炎症的影响。行为学实验后进行PET-CT扫描并对PET图像进行定量分析;收集小鼠脑组织样本进行免疫荧光染色,采用Image J对海马区域Iba-1细胞、 TSPO免疫荧光强度进行统计;将小鼠海马体在冰上分离,并立即在液氮中快速冷冻,然后储存在-80 ℃下进行随后的RNA提取,试剂盒检测肿瘤坏死因子-α(tumor necrosis factor-α,TNF-α)、白细胞介素1β(interleukin-1 beta,IL-1β)和IL-4含量。 结果 与对照组相比,CSDS应激后,小鼠表现出低糖水偏好比(P=0.003)低社会交互比(P=0.000)、更长的不动时间(P=0.002),在海马区域,小胶质细胞活化,表现为SUV值升高(P=0.020),Iba-1和TSPO的免疫荧光强度增强(P=0.000)和促炎细胞因子IL-1β和TNF-α升高(P=0.016、0.036)。而MaR1改善了上述CSDS诱导的抑郁样行为,抑制小胶质细胞的激活和减少促炎因子的表达。 结论 MaR1能够缓解CSDS诱导的青少年期小鼠抑郁样行为,抑制小胶质细胞的活化。神经炎症是青少年抑郁症的潜在致病因素,具有抗炎特性的药物如MaR1有潜力作为临床相关的抗抑郁药,需要进一步地研究。

Abstract

Objective To elucidate the effect of Maresin-1(MaR1) on chronic social defeated stress(CSDS)-induced depression-like behaviors in adolescent mice(5-8 weeks old),validate its role in CSDS-induced neuroinflammation,and provide a reference for understanding the molecular mechanisms of depression and exploring biomarkers. Methods Multiple methods were used to measure depression-like behaviors and neuroinflammation in C57BL/6J mice ten days after CSDS induction. The mice were treated with MaR1(5 µg/kg) intravenously every two days to observe its effect on CSDS-induced depression-like behaviors and neuroinflammation. Behavioral experiments were followed by positron emission tomography-computerized tomography(PET-CT) scanning and quantitative analysis of PET images. The mouse brain tissue samples were collected for immunofluorescence staining,and the immunofluorescence intensities of Iba-1 cells in the hippocampal region and translocator protein(TSPO) were calculated using Image J. The mouse hippocampus was dissected on ice,immediately frozen in liquid nitrogen,and stored at -80°C for subsequent RNA extraction. A kit was used to measure the levels of tumor necrosis factor-α(TNF-α),interleukin-1 beta(IL-1β),and IL-4. Results Compared to the control group,mice subjected to CSDS stress showed a lower sucrose preference ratio(P=0.003),lower social interaction ratio(P=0.000),longer immobility time(P=0.002),and microglial cell activation in the hippocampal region evidenced by increased standardized uptake values(P=0.020),enhanced immunofluorescence intensity of Iba-1 and TSPO(P=0.000),and increased proinflammatory cytokines IL-1β and TNF-α(P=0.016,0.036). In contrast,MaR1 improved CSDS-induced depression-like behaviors,inhibited microglia activation,and reduced the expression of proinflammatory factors. Conclusion MaR1 can alleviate CSDS-induced depression-like behaviors in adolescent mice and inhibit the activation of microglia. Neuroinflammation is a potential pathogenic factor for depression in adolescents,and drugs with anti-inflammatory properties such as MaR1 hold promise for use as a clinically relevant antidepressant,which needs further investigation.

关键词

青少年 / 抑郁症 / 小胶质细胞 / [18F]DPA-714PET / Maresin-1

Key words

adolescent / depression / microglia / [18F]DPA-714PET / Maresin-1

中图分类号

R749.4

引用本文

导出引用
陈羽佳 , 石磊 , 徐何雁 , . Maresin-1改善青少年期抑郁小鼠的抑郁样行为和神经炎症. 重庆医科大学学报. 2024, 49(04): 465-470 https://doi.org/10.13406/j.cnki.cyxb.003469
Chen Yujia, Shi lei, Xu Heyan, et al. Improvement of depression-like behaviors and neuroinflammation in adolescent depressed mice using Maresin-1[J]. Journal of Chongqing Medical University. 2024, 49(04): 465-470 https://doi.org/10.13406/j.cnki.cyxb.003469

参考文献

1
GBD Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories,1990-2019:a systematic analysis for the Global Burden of Disease Study 2019[J]. Lancet2020396(10258):1204-1222.
2
Shorey S Ng ED Wong CHJ. Global prevalence of depression and elevated depressive symptoms among adolescents:a systematic review and meta-analysis[J]. Br J Clin Psychol202261(2):287-305.
3
Rao WW Xu DD Cao XL,et al. Prevalence of depressive symptoms in children and adolescents in China:a meta-analysis of observational studies[J]. Psychiatry Res2019272:790-796.
4
Korczak DJ Westwell-Roper C Sassi R. Diagnosis and management of depression in adolescents[J]. CMAJ2023195(21):E739-E746.
5
Locher C Koechlin H Zion SR,et al. Efficacy and safety of selective serotonin reuptake inhibitors,serotonin-norepinephrine reuptake inhibitors,and placebo for common psychiatric disorders among children and adolescents:a systematic review and meta-analysis[J]. JAMA Psychiatry201774(10):1011-1020.
6
Brydges CR Bhattacharyya S Dehkordi SM,et al. Metabolomic and inflammatory signatures of symptom dimensions in major depression[J]. Brain Behav Immun2022102:42-52.
7
Troubat R Barone P Leman S,et al. Neuroinflammation and depression:a review[J]. Eur J Neurosci202153(1):151-171.
8
Harsanyi S Kupcova I Danisovic L,et al. Selected biomarkers of depression:what are the effects of cytokines and inflammation?[J]. Int J Mol Sci202224(1):578.
9
Kwon HS Koh SH. Neuroinflammation in neurodegenerative disorders:the roles of microglia and astrocytes[J]. Transl Neurodegener20209(1):42.
10
Réus GZ Manosso LM Quevedo J,et al. Major depressive disorder as a neuro-immune disorder:origin,mechanisms,and therapeutic opportunities[J]. Neurosci Biobehav Rev2023155:105425.
11
Wei JH Su WF Zhao YY,et al. Maresin 1 promotes nerve regeneration and alleviates neuropathic pain after nerve injury[J]. J Neuroinflammation202219(1):32.
12
Qiu T Li X Chen WJ,et al. Prospective study on Maresin-1 and cytokine levels in medication-naïve adolescents with first-episode major depressive disorder[J]. Front Psychiatry202314:1132791.
13
Liu MY Yin CY Zhu LJ,et al. Sucrose preference test for measurement of stress-induced anhedonia in mice[J]. Nat Protoc201813(7):1686-1698.
14
Golden SA Covington HE 3rd Berton O,et al. A standardized protocol for repeated social defeat stress in mice[J]. Nat Protoc20116(8):1183-1191.
15
Shi XY Bai HY Wang JM,et al. Behavioral assessment of sensory,motor,emotion,and cognition in rodent models of intracerebral hemorrhage[J]. Front Neurol202112:667511.
16
Primo MJ Fonseca-Rodrigues D Almeida A,et al. Sucrose preference test:a systematic review of protocols for the assessment of anhedonia in rodents[J]. Eur Neuropsychopharmacol202377:80-92.
17
Borst K Dumas AA Prinz M. Microglia:immune and non-immune functions[J]. Immunity202154(10):2194-2208.
18
Rupprecht R Wetzel CH Dorostkar M,et al. Translocator protein (18kDa) TSPO:a new diagnostic or therapeutic target for stress-related disorders?[J]. Mol Psychiatry202227(7):2918-2926.
19
Eggerstorfer B Kim JH Cumming P,et al. Meta-analysis of molecular imaging of translocator protein in major depression[J]. Front Mol Neurosci202215:981442.
20
Shi L Xia Z Guo JM,et al. Maresin-1 improves LPS-induced depressive-like behavior by inhibiting hippocampal microglial activation[J]. J Affect Disord2023328:261-272.
21
Qiu T Guo JM Wang LX,et al. Dynamic microglial activation is associated with LPS-induced depressive-like behavior in mice:an[18F]DPA-714 PET imaging study[J]. Bosn J Basic Med Sci202222(4):649-659.
22
Guo JM Qiu T Wang LX,et al. Microglia loss and astrocyte activation cause dynamic changes in hippocampal[18F]DPA-714 uptake in mouse models of depression[J]. Front Cell Neurosci202216:802192.
23
Ho TC Kulla A Teresi GI,et al. Inflammatory cytokines and callosal white matter microstructure in adolescents[J]. Brain Behav Immun2022100:321-331.
24
Pallavi P Sagar R Mehta M,et al. Serum cytokines and anxiety in adolescent depression patients:gender effect[J]. Psychiatry Res2015229(1/2):374-380.
25
Rengasamy M Marsland A McClain L,et al. Longitudinal relationships of cytokines,depression and anhedonia in depressed adolescents[J]. Brain Behav Immun202191:74-80.
26
Wachholz S Knorr A Mengert L,et al. Interleukin-4 is a participant in the regulation of depressive-like behavior[J]. Behav Brain Res2017326:165-172.

评论

PDF(1943 KB)

Accesses

Citation

Detail

段落导航
相关文章

/